Integrated Advisors Network’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-2,873
Closed -$213K – 733
2024
Q4
$213K Buy
+2,873
New +$201K 0.01% 658
2024
Q3
– Sell
-4,497
Closed -$415K – 722
2024
Q2
$415K Sell
4,497
-9,282
-67% -$822K 0.02% 499
2024
Q1
$1.32M Buy
13,779
+8,214
+148% +$690K 0.07% 260
2023
Q4
$424K Sell
5,565
-452
-8% -$31.5K 0.02% 477
2023
Q3
$417K Sell
6,017
-16,201
-73% -$1.3M 0.03% 472
2023
Q2
$2.1M Sell
22,218
-932
-4% -$81K 0.12% 193
2023
Q1
$1.92M Buy
23,150
+299
+1% +$23.5K 0.12% 192
2022
Q4
$1.7M Buy
22,851
+4,409
+24% +$340K 0.11% 203
2022
Q3
$1.52M Sell
18,442
-287
-2% -$27.6K 0.1% 203
2022
Q2
$1.78M Buy
18,729
+11,268
+151% +$1.17M 0.12% 197
2022
Q1
$878K Sell
7,461
-28
-0.4% -$3.14K 0.05% 331
2021
Q4
$970K Buy
7,489
+154
+2% +$18K 0.06% 293
2021
Q3
$830K Buy
7,335
+509
+7% +$58.1K 0.06% 304
2021
Q2
$707K Buy
6,826
+105
+2% +$9.9K 0.05% 291
2021
Q1
$562K Buy
6,721
+270
+4% +$22.8K 0.05% 312
2020
Q4
$589K Buy
6,451
+20
+0.3% +$1.66K 0.06% 259
2020
Q3
$513K Buy
6,431
+29
+0.5% +$2.26K 0.06% 247
2020
Q2
$443K Buy
6,402
+243
+4% +$17.3K 0.05% 275
2020
Q1
$387K Sell
6,159
-36
-0.6% -$2.6K 0.08% 221
2019
Q4
$482K Buy
+6,195
New +$484K 0.07% 252

Other funds holding EW

Integrated Advisors Network's EW Position: Q1 2025 in Review

Integrated Advisors Network sold out of Edwards Lifesciences (EW) in Q1 2025, closing a stake of 2,873 shares — an estimated $213K sold.

Integrated Advisors Network first reported a position in EW in Q4 2019 and held it in 20 quarters. The position peaked at $2.1M in Q2 2023. 1,207 funds tracked by Wall St. Rank hold EW as of Q1 2025.

  • Integrated Advisors Network reported no remaining Edwards Lifesciences position as of Q1 2025 after selling out during the quarter.
  • Integrated Advisors Network sold 2,873 Edwards Lifesciences shares in Q1 2025, an estimated $213K.
  • Integrated Advisors Network first reported a position in Edwards Lifesciences in Q4 2019 and held it in 20 quarters.
  • Integrated Advisors Network's Edwards Lifesciences position peaked at $2.1M in Q2 2023.
  • 1,207 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2025.

Based on Integrated Advisors Network's 13F filing for Q1 2025, filed 15 Apr 2025.